Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Winssinger

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
Nature Biotechnology|April 30, 2024
Development of supramolecular anticoagulants with on-demand reversibilityMillicent Dockerill, Daniel J Ford, Simona Angerani, et al.
Frontiers in Oncology|April 5, 2021
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and BeyondMichael Orth, Valerie Albrecht, Karin Seidl, et al.
Oncotarget|June 4, 2016
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancerLinda Kinzel, Anne Ernst, Michael Orth, et al.
Cancer Immunology Research|September 13, 2024
PTPRZ1-Targeting RNA CAR T Cells Exert Antigen-Specific and Bystander Antitumor Activity in GlioblastomaDarel Martinez Bedoya, Eliana Marinari, Suzel Davanture, et al.
European Journal of Clinical Investigation|July 29, 2021
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1Sabrina Pagano, Sabine Yerly, Benjamin Meyer, et al.
Chimia|December 18, 2021
Flipper Probes for the CommunityLea Assies, José García-Calvo, Francesca Piazzolla, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Nature Biotechnology|April 30, 2024
Development of supramolecular anticoagulants with on-demand reversibilityMillicent Dockerill, Daniel J Ford, Simona Angerani, et al.
Frontiers in Oncology|April 5, 2021
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and BeyondMichael Orth, Valerie Albrecht, Karin Seidl, et al.
Oncotarget|June 4, 2016
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancerLinda Kinzel, Anne Ernst, Michael Orth, et al.
Cancer Immunology Research|September 13, 2024
PTPRZ1-Targeting RNA CAR T Cells Exert Antigen-Specific and Bystander Antitumor Activity in GlioblastomaDarel Martinez Bedoya, Eliana Marinari, Suzel Davanture, et al.
European Journal of Clinical Investigation|July 29, 2021
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1Sabrina Pagano, Sabine Yerly, Benjamin Meyer, et al.
Chimia|December 18, 2021
Flipper Probes for the CommunityLea Assies, José García-Calvo, Francesca Piazzolla, et al.
Pageof 16